» Articles » PMID: 22723916

Three Linked Vasculopathic Processes Characterize Kawasaki Disease: a Light and Transmission Electron Microscopic Study

Abstract

Background: Kawasaki disease is recognized as the most common cause of acquired heart disease in children in the developed world. Clinical, epidemiologic, and pathologic evidence supports an infectious agent, likely entering through the lung. Pathologic studies proposing an acute coronary arteritis followed by healing fail to account for the complex vasculopathy and clinical course.

Methodology/principal Findings: Specimens from 32 autopsies, 8 cardiac transplants, and an excised coronary aneurysm were studied by light (n=41) and transmission electron microscopy (n=7). Three characteristic vasculopathic processes were identified in coronary (CA) and non-coronary arteries: acute self-limited necrotizing arteritis (NA), subacute/chronic (SA/C) vasculitis, and luminal myofibroblastic proliferation (LMP). NA is a synchronous neutrophilic process of the endothelium, beginning and ending within the first two weeks of fever onset, and progressively destroying the wall into the adventitia causing saccular aneurysms, which can thrombose or rupture. SA/C vasculitis is an asynchronous process that can commence within the first two weeks onward, starting in the adventitia/perivascular tissue and variably inflaming/damaging the wall during progression to the lumen. Besides fusiform and saccular aneurysms that can thrombose, SA/C vasculitis likely causes the transition of medial and adventitial smooth muscle cells (SMC) into classic myofibroblasts, which combined with their matrix products and inflammation create progressive stenosing luminal lesions (SA/C-LMP). Remote LMP apparently results from circulating factors. Veins, pulmonary arteries, and aorta can develop subclinical SA/C vasculitis and SA/C-LMP, but not NA. The earliest death (day 10) had both CA SA/C vasculitis and SA/C-LMP, and an "eosinophilic-type" myocarditis.

Conclusions/significance: NA is the only self-limiting process of the three, is responsible for the earliest morbidity/mortality, and is consistent with acute viral infection. SA/C vasculitis can begin as early as NA, but can occur/persist for months to years; LMP causes progressive arterial stenosis and thrombosis and is composed of unique SMC-derived pathologic myofibroblasts.

Citing Articles

Clinical characteristics of Kawasaki disease with pulmonary radiographic abnormalities and its impact on the incidence of coronary artery lesions: a randomized retrospective cohort study.

Liu C, Rong X, Qiu H, Zhou J, Chen Y, Huang X Front Pediatr. 2025; 13:1506735.

PMID: 39981208 PMC: 11839633. DOI: 10.3389/fped.2025.1506735.


Risk factors for predicting medium-giant coronary artery aneurysms in Kawasaki disease.

Zhao L, Wu J, Liu X, Zhou K, Hua Y, Shao S Immunol Res. 2025; 73(1):52.

PMID: 39960616 DOI: 10.1007/s12026-025-09604-x.


A Nomogram Model for Predicting Recurrent Coronary Thrombosis in Kawasaki Disease Patients.

Zhou X, Peng Y, Yi Q J Inflamm Res. 2025; 18():105-114.

PMID: 39780986 PMC: 11705992. DOI: 10.2147/JIR.S473511.


Endothelial Dysfunction: Molecular Mechanisms and Therapeutic Strategies in Kawasaki Disease.

Paolini L, Guida F, Calvaruso A, Andreozzi L, Pierantoni L, Lanari M Int J Mol Sci. 2025; 25(24.

PMID: 39769085 PMC: 11676170. DOI: 10.3390/ijms252413322.


Statin suppresses the development of excessive intimal proliferation in a Kawasaki disease mouse model.

Motoji Y, Fukazawa R, Matsui R, Watanabe M, Hashimoto Y, Nagi-Miura N Physiol Rep. 2024; 12(20):e70096.

PMID: 39424429 PMC: 11489001. DOI: 10.14814/phy2.70096.


References
1.
Yoganathan K, Goodman F, Pozniak A . Kawasaki-like syndrome in an HIV positive adult. J Infect. 1995; 30(2):165-6. DOI: 10.1016/s0163-4453(95)80014-x. View

2.
Suzuki A, Miyagawa-Tomita S, Nakazawa M, Yutani C . Remodeling of coronary artery lesions due to Kawasaki disease: comparison of arteriographic and immunohistochemical findings. Jpn Heart J. 2000; 41(3):245-56. DOI: 10.1536/jhj.41.245. View

3.
Suzuki A, Miyagawa-Tomita S, Komatsu K, Nishikawa T, Sakomura Y, Horie T . Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease: immunohistochemical study. Circulation. 2000; 101(25):2935-41. DOI: 10.1161/01.cir.101.25.2935. View

4.
Takahashi K, Oharaseki T, Yokouchi Y, Hiruta N, Naoe S . Kawasaki disease as a systemic vasculitis in childhood. Ann Vasc Dis. 2013; 3(3):173-81. PMC: 3595783. DOI: 10.3400/avd.sasvp01003. View

5.
Hinz B, Phan S, Thannickal V, Galli A, Bochaton-Piallat M, Gabbiani G . The myofibroblast: one function, multiple origins. Am J Pathol. 2007; 170(6):1807-16. PMC: 1899462. DOI: 10.2353/ajpath.2007.070112. View